News from NORD

NORD to Moderate Panel at NIH Rare Disease Day Event


 

NORD Board Chair Marshall Summar, MD, of Children’s National Health System, will moderate a panel on the importance of collaborating with patient organizations in rare disease research at the annual National Institutes of Health (NIH) Rare Disease Day event on March 1, 2018. The event is open to the public and will be webcast. Other speakers will include NIH Director Francis Collins, MD, PhD; representatives of the Rare Disease Congressional Caucus; NIH researchers; and leaders of patient organizations. Topics will include gene therapy, gene editing, and engaging the next generation of the rare diseases community. For information or to register, visit the NIH web page .

Recommended Reading

FDA Issues Guidance for More Efficient Approach to Drug Development for Rare Pediatric Diseases
MDedge Dermatology
NIH Undiagnosed Diseases Network to Offer Grand Rounds Webinar Series
MDedge Dermatology
Disfiguring Ulcerative Neutrophilic Dermatosis Secondary to Doxycycline and Isotretinoin in an Adolescent Boy With Acne Conglobata
MDedge Dermatology
Cases link vitiligoid lichen sclerosus and darker skin
MDedge Dermatology
Differentiating Trigeminal Motor Neuropathy and Progressive Hemifacial Atrophy
MDedge Dermatology
Yellow-Orange Hairless Plaque on the Scalp
MDedge Dermatology
Tumor Necrosis Factor α Inhibitors in the Treatment of Toxic Epidermal Necrolysis
MDedge Dermatology
Primary Cutaneous Follicle Center Lymphoma Mimicking Folliculitis
MDedge Dermatology
Melkersson-Rosenthal Syndrome Successfully Treated With Adalimumab
MDedge Dermatology
Panniculitis, Pancreatitis, and Polyarthritis: A Rare Clinical Syndrome
MDedge Dermatology